Current medical treatment boils down to six words: Have disease, take pill, kill something. But physician Siddhartha Mukherjee points to a future of medicine that will transform the way we heal.
Read more
Category: biotech/medical – Page 2,309
Clinton Township, MI
Posted in biotech/medical, cryonics, education, life extension
UNITY Biotechnologies has recently announced an expansion of its first-stage human trial of UBX0101, a drug that has been shown to have senolytic properties in mice [1] and that the company hopes will be useful in treating painful osteoarthritis of the knee.
An expanded clinical trial
UNITY Biotechnologies, a $495 million biotech company in the process of creating senolytic medicines that target one of the aging processes, has just announced an expansion of its first-stage human trial of the first drug in its pipeline (UBX0101), which targets painful osteoarthritis of the knee.
Read more
(CNN) — Intensive lowering of blood pressure, to a less than 120 mm Hg level, can have a measurable impact on mild cognitive impairment (MCI) — a well-established precursor of dementia, a new study finds.
Previous studies have suggested high blood pressure could be a risk factor for dementia and mild cognitive impairment, leading US researchers to explore whether lowering pressure could reduce this risk in a large randomized trial on more than 9000 people.
Lowering blood pressure did not significantly reduce dementia risk, but the secondary results showed a significant reduction in MCI, according to the study published Monday.
Read more
Researchers are always looking for new materials that can help power electronics and medical devices in the future. MIT has made a breakthrough with a new material that makes that goal closer to reality. The breakthrough is thanks to a fully flexible device that can convert WiFi signals into electricity that could power devices.
Read more
For a long time, biohackers have been playing with magnets by embedding then under their skin as a novelty extra-sensation. I, personally, don’t see the point, but morphological, taxonomic, and cladic freedom are at work so I celebrate their actions.
Our skin’s ability to perceive pressure, heat, cold, and vibration is a critical safety function that most people take for granted. But burn victims, those with prosthetic limbs, and others who have lost skin sensitivity for one reason or another, can’t take it for granted, and often injure themselves unintentionally.
Chemists Islam Mosa from UConn, and James Rusling from UConn and UConn Health, along with University of Toronto engineer Abdelsalam Ahmed, wanted to create a sensor that can mimic the sensing properties of skin. Such a sensor would need to be able to detect pressure, temperature, and vibration. But perhaps it could do other things too, the researchers thought.
“It would be very cool if it had abilities human skin does not; for example, the ability to detect magnetic fields, sound waves, and abnormal behaviors,” said Mosa.
Read more
The gut microbiome is made up of billions of bacteria, and scientists have been trying to understand exactly how they affect our health, contribute to our risk of contacting diseases and how they interact with the vital organs and systems in the body, including the brain. It is quite a lot to unpick.
As countries industrialise, their air becomes dirtier – and this could have some far-reaching effects on the beneficial bacteria inside us.
Read more
This is not hyperbole. AMR already leads to at least 700,000 deaths every year. But the impact goes further — resistant genes in people and animals cross ecological, species and geographical borders. Progress against diseases including HIV, malaria and tuberculosis is threatened globally. In 2016, the World Health Organization reported that nearly half a million people developed drug-resistant tuberculosis. Even cancer patients are more at risk as most treatments suppress the immune system and would, along with several routine surgical operations, become too risky without effective antibiotics.
The world urgently needs a new financing model for antibiotics.
Read more